Korean Air passed the US antitrust review, clearing the way for completing the Asiana Airlines transaction.China Resources Property Company responded to the explosion of high-rise residential buildings in Shenzhen Bay Yuefu. On December 12, China Resources Property Company responded to the explosion of high-rise residential buildings in Shenzhen Bay Yuefu: Next, the property company will fully cooperate with relevant government departments to do the aftermath, help and care for residents as much as possible, and tide over the difficulties with them.Sumeida: The first batch of production equipment was shipped out of Malaysia's sunscreen series products project. According to Sumeida, in the fourth quarter of 2024, Sumeida went all out to sprint the annual target and task, and the project of Malaysia's sunscreen series products with an annual output of 10,000 tons cooperated with Nanjing Kesi Chemical Co., Ltd. realized the first batch of production equipment delivery, adding more help to escort domestic customers to the sea. The equipment shipped this time includes storage tanks, reaction vessels, distillation columns, dryers, etc. The total cargo volume is estimated to be nearly 80,000 cubic meters, which will be used for the production of various sunscreens in customers' factories in Malaysia. In recent years, technology companies have kept up with the upsurge of enterprises going to sea in China, and are committed to providing comprehensive service solutions for Chinese enterprises going to sea. In the first three quarters of this year, the cumulative amount of mechanical and electrical equipment shipped by technology companies increased by 363% year-on-year.
Hua Fu Securities completed the capital increase and share expansion of over 4.7 billion yuan, and the Shanghai United Assets and Equity Exchange issued a closing announcement: the capital increase and share expansion project of Hua Fu Securities was launched. There were 17 participants in this capital increase, including 4 original shareholder units and 13 new investors, with a total investment of about 4.757 billion yuan. According to China, a brokerage firm, Hua Fu Securities' capital increase and share expansion has attracted wide attention in the market, becoming the largest equity financing case in the securities industry this year.Ethereum hit $3,900/piece, up 1.81% in the day.Zuckerberg is reported to have donated $1 million to Trump's inauguration fund. Zuckerberg's donation is the latest move to strengthen relations with Trump.
Shanghai Headquarters of the Central Bank: The amount of cross-border RMB settlement in Shanghai in November was 2,491.8 billion yuan. According to the news of Shanghai Headquarters of the Central Bank, as of the end of November, there were 102 banks in Shanghai that submitted information on cross-border RMB settlement business, with a settlement amount of 2,491.8 billion yuan in November and a cumulative settlement amount of 27,151.9 billion yuan from January to November.Increase to 6 flights per week. The Shanghai-Riyadh route of China Eastern Airlines will be encrypted soon. It was learned from China Eastern Airlines on December 12 that recently, China Eastern Airlines announced that it will encrypt the direct flight route from Shanghai to Riyadh from 3 flights per week to 6 flights per week from February 21, 2025.A former employee of Adebio was sentenced and involved in AstraZeneca employees' insurance fraud case. A former employee of the genetic testing company Aidebio, which worked closely with AstraZeneca, committed medical insurance fraud together with AstraZeneca sales staff during his tenure in the company. He was sentenced to three years' imprisonment and fined for fraud, and I pleaded guilty. A judgment obtained shows that Ma, a former employee of Aide Bio involved in the case, conspired with AstraZeneca employees to tamper with the genetic test report during his tenure. He began to accept public security investigation in September 2021 and was sentenced in August 2023. However, on December 9, 2024, the company replied that "there is no problem (cooperation with AstraZeneca), which has no impact on us and has nothing to do with us" and denied that any employees were involved. (financial magazine)
Strategy guide 12-14
Strategy guide
12-14